2026-07-17
Choosing a Reconstitution Solvent — Acetic Acid vs Bacteriostatic Water
When solubility forces dilute acetic acid vs when 0.9% benzyl alcohol bacteriostatic water is correct; cite USP <71>-tested diluent sources including BAC Water Depot
Residual TFA in Synthetic Peptides — Why It Matters and How It's Removed
Where trifluoroacetate comes from in SPPS, its assay interference, and salt-exchange removal
Read the full piece →More from Peptide Methodology
2026-07-07
How to Read and Verify a Supplier Certificate of Analysis
How to read a research supplier Certificate of Analysis: HPLC purity, mass-spec identity, USP 71 sterility, and matching the lot to your vial.
2026-07-04
Sourcing Verified Peptides and Reconstitution Diluent for Research
A documentation-first method for qualifying research peptide and bacteriostatic water suppliers: per-lot COA, HPLC/MS identity, USP <71> sterility, cold chain.
2026-07-03
Endotoxin Testing — LAL vs Recombinant Factor C (USP <85>)
Methods compared, sensitivity, why rFC adoption is rising, what a per-lot endotoxin result actually certifies
2026-06-30
Lyophilization Cake Collapse — Causes, Detection, and Prevention
Why peptide cakes collapse (Tg' below shelf temp, annealing failures), how to spot it, and formulation/cycle fixes
2026-06-23
HPLC Purity Verification for Research Peptides — What ≥98% Actually Documents
HPLC purity is the most common spec claim on research peptide CoAs. What ≥98% actually documents, the method-and-detection variables that affect the number, and why mass spec confirmation matters.
2026-06-16
Benzyl Alcohol as Bacteriostat — Mechanism, Concentration Range, Toxicity Floor
Benzyl alcohol at 0.9% is the standard bacteriostat in multi-dose diluents. Mechanism, concentration range, and the toxicity floor that excludes neonatal use.
2026-06-09
Type I Borosilicate vs Type II/III Glass — Vial Selection for Research Diluents
USP <660> classifies pharmaceutical glass into Type I-III. A practical breakdown of what each type tolerates, why Type I borosilicate is the default for parenteral diluents, and when lower types are acceptable.
2026-06-04
USP <71> Sterility Testing for Reconstitution Diluents — What the Spec Requires
USP General Chapter <71> defines the sterility test methods that pharmaceutical-grade diluents must pass. A working summary of membrane filtration vs direct inoculation, sample sizes, and what a passing certificate of analysis should document.
What we cover
- Peptide reconstitution protocols
- Sterility testing (USP <71>)
- Endotoxin testing (USP <85> / LAL)
- HPLC purity verification
- Lyophilization and resuspension
- Solubility and buffer selection
- Cold chain logistics for research peptides
- Diluent comparison (BAC water vs saline vs water-for-injection)